Multiple sclerosis and Prolactinoma

Summary:

Prolactinoma is found among people with Multiple sclerosis, especially for people who are female, 40-49 old.

The study analyzes which people have Prolactinoma with Multiple sclerosis. It is created by eHealthMe based on reports of 16 people who have Multiple sclerosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Multiple sclerosis?

Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) is found to be associated with 1,084 drugs and 1,366 conditions by eHealthMe. Check the latest studies of Multiple sclerosis.

What is Prolactinoma?

Prolactinoma (benign tumour (adenoma) of the pituitary gland that produces a hormone called prolactin) is found to be associated with 19 drugs and 158 conditions by eHealthMe. Check the latest studies of Prolactinoma.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 17, 2026

16 people who have Multiple Sclerosis and Prolactinoma are studied.

Would you have Prolactinoma when you have Multiple sclerosis?

Gender of people who have Multiple Sclerosis and experienced Prolactinoma *:

  • female: 80 %
  • male: 20 %

Age of people who have Multiple Sclerosis and experienced Prolactinoma *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 16.67 %
  • 30-39: 16.67 %
  • 40-49: 50.0 %
  • 50-59: 8.33 %
  • 60+: 8.33 %

Common co-existing conditions for these people *:

  1. Type 1 Diabetes: 3 people, 18.75%
  2. High Blood Pressure: 2 people, 12.50%
  3. Secondary Progressive Multiple Sclerosis (a stage of ms which comes after relapsing remitting ms in many cases): 1 person, 6.25%
  4. Paroxysmal Nocturnal Haemoglobinuria (haemoglobin in the urine): 1 person, 6.25%
  5. Birth Control: 1 person, 6.25%

Common drugs taken by these people *:

  1. Avonex: 6 people, 37.50%
  2. Tysabri: 5 people, 31.25%
  3. Rebif: 4 people, 25.00%
  4. Lisinopril: 3 people, 18.75%
  5. Lantus: 3 people, 18.75%
  6. Soliris: 1 person, 6.25%
  7. Paracetamol: 1 person, 6.25%
  8. Pantoprazole: 1 person, 6.25%
  9. Lovaza: 1 person, 6.25%
  10. Gilenya: 1 person, 6.25%

Common symptoms for these people *:

  1. Amenorrhea (absence of a menstrual period in a woman of reproductive age): 6 people, 37.50%
  2. Hypoaesthesia (reduced sense of touch or sensation): 4 people, 25.00%
  3. Memory Loss: 3 people, 18.75%
  4. Weakness: 3 people, 18.75%
  5. Heart Rate Irregular: 3 people, 18.75%
  6. Heart Disease: 3 people, 18.75%
  7. Fear: 3 people, 18.75%
  8. Irritability: 3 people, 18.75%
  9. Chest Pain: 3 people, 18.75%
  10. Balance Disorder: 3 people, 18.75%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Prolactinoma?

- Check whether Prolactinoma is associated with a drug or a condition


Related publications that referenced our studies

Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Prolactinoma:

All the conditions that are associated with Prolactinoma:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Prolactinoma and Multiple sclerosis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: